Increasing Parasitic Infections To Drive Market Growth For Anthelmintic Drugs: An Emerging Driver Transforming The Anthelmintic Drugs Market Landscape

The Anthelmintic Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Anthelmintic Drugs Market?
The market size for anthelmintic drugs has seen a robust growth over the previous years. It is projected to expand from $3.16 billion in 2024 to $3.34 billion in 2025, registering a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historic period is due to factors such as the high frequency of helminth infections, surge in public health initiatives, increase in research and development in the pharmaceutical sector, enhanced awareness and education, and economic development.

The market for anthelmintic drugs is set to experience robust expansion in the upcoming years, projected to reach $4.11 billion by 2029, rising at a compound annual growth rate (CAGR) of 5.3%. This projected growth for the forecast period is due in part to the global rise in parasitic infections, increased usage of anthelmintics for livestock and pet care, heightened public awareness, and health initiatives, along with the growth in international travel. Key trends that are anticipated to shape the market during the forecast period encompass the growing demand for combination treatments, an enhanced focus on managing drug resistance, the rise in the adoption of personalized medicine, the proliferation of telemedicine in treatment monitoring, increased research into new drug targets, and the prioritization of preventive healthcare methods.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291

What Are the Different Anthelmintic Drugs Market Segments?
The anthelmintic drugsmarket covered in this report is segmented -

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What Are the Primary Drivers Shaping the Anthelmintic Drugs Market?
The anthelmintic drugs market is anticipated to expand owing to the high occurrence of parasitic infections. These infections originate from organisms, like protozoa, worms, or ectoparasites, that inhabit or live on another host. Factors such as poor sanitation, contaminated resources, insufficient hygiene, close interaction with infected persons or animals, and a shortage of access to clean resources fuel the prevalence of parasitic infections. Anthelmintic drugs, geared to manage infections by parasitic worms, operate by interrupting the physiological functions of these parasites, facilitating their elimination or death. For example, the Centers for Disease Control and Prevention reported a twofold increase in cases of cyclosporiasis, caused by a microscopic parasite, in Florida in July 2023. These cases surged from 254 in 2021 to 513 in 2022. As such, the escalation in parasitic infections is catalyzing the growth of the anthelmintic drugs market.

Which Companies Are Leading in the Anthelmintic Drugs Market?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

What Are the Major Trends Shaping the Anthelmintic Drugs Market?
The focus of leading players in the anthelmintic drugs market is on advancing innovative combination drugs that provide broad-ranging protection against multiple parasites. These combination anthelmintic drugs are concoctions of two or more anthelmintic components that augment their potency against parasitic infections, applicable to both humans and animals. They function in a synergistic manner to widen the scope of activity and slow down drug resistance development, besides counteracting existing parasite resistance patterns. For example, in January 2022, Zoetis Inc., an American animal health company, attained approval from the U.S. Food and Drug Administration for a new label indication for Simparica Trio, which effectively prevents infections instigated by Borrelia burgdorferi, the causative organism for canine Lyme disease. Simparica Trio merges three potent components, namely sarolaner, moxidectin and pyrantel, offering thorough protection against fleas, ticks, heartworms, roundworms and hookworms.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

What Are the Top Revenue-Generating Geographies in the Anthelmintic Drugs Market?
North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anthelmintic Drugs Market?
2. What is the CAGR expected in the Anthelmintic Drugs Market?
3. What Are the Key Innovations Transforming the Anthelmintic Drugs Industry?
4. Which Region Is Leading the Anthelmintic Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.